Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Immunocore Holdings plc - American Depositary Shares
(NQ:
IMCR
)
29.91
-0.13 (-0.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Immunocore Holdings plc - American Depositary Shares
< Previous
1
2
3
4
Next >
Immunocore (IMCR) Q4 2025 Earnings Call Transcript
↗
February 25, 2026
Immunocore (IMCR) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Immunocore (IMCR) Q2 2025 Earnings Call Transcript
↗
November 27, 2025
Immunocore (IMCR) Q2 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Growth Picks: 3 Low-Cost Stocks That Could Double in Value
↗
October 27, 2025
Via
MarketBeat
Immunocore (IMCR) Q2 Revenue Jumps 30%
↗
August 07, 2025
Via
The Motley Fool
Topics
Earnings
Intellectual Property
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Demystifying Immunocore Holdings: Insights From 9 Analyst Reviews
↗
June 02, 2025
Via
Benzinga
What Analysts Are Saying About Immunocore Hldgs Stock
↗
February 27, 2025
Via
Benzinga
Immunocore Holdings PLC (NASDAQ:IMCR) Beats Q2 2025 Revenue and EPS Estimates with Strong KIMMTRAK Sales Growth
↗
August 07, 2025
Immunocore (IMCR) beat Q2 2025 estimates with $98M revenue (+30% YoY) and a narrower EPS loss. KIMMTRAK sales surged 32%, while pipeline progress and strong cash position ($882.8M) boosted investor...
Via
Chartmill
Analyst Expectations For Immunocore Holdings's Future
↗
April 07, 2025
Via
Benzinga
Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday
↗
March 20, 2025
Via
Benzinga
Earnings Scheduled For February 26, 2025
↗
February 26, 2025
Via
Benzinga
Analyst Expectations For Immunocore Hldgs's Future
↗
January 27, 2025
Via
Benzinga
Navigating 8 Analyst Ratings For Immunocore Hldgs
↗
November 11, 2024
Via
Benzinga
A Closer Look at 9 Analyst Recommendations For Immunocore Hldgs
↗
October 24, 2024
Via
Benzinga
Analyst Ratings For Immunocore Hldgs
↗
October 07, 2024
Via
Benzinga
Analyst Expectations For Immunocore Hldgs's Future
↗
September 17, 2024
Via
Benzinga
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
↗
December 13, 2024
Morgan Stanley downgrades Amicus Therapeutics, Immunocore, and Immuneering, citing pricing challenges, pipeline updates, and cautious growth outlooks.
Via
Benzinga
3 Fast-Growing Stocks Analysts See Doubling in Price
November 11, 2024
Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.
Via
MarketBeat
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
September 17, 2024
Via
Benzinga
The Latest Analyst Ratings For Immunocore Hldgs
↗
August 28, 2024
Via
Benzinga
Deep Dive Into Immunocore Hldgs Stock: Analyst Perspectives (9 Ratings)
↗
August 09, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Immunocore Hldgs Through Analyst Insights
↗
July 10, 2024
Via
Benzinga
Analyst Expectations For Immunocore Hldgs's Future
↗
May 24, 2024
Via
Benzinga
Where Immunocore Hldgs Stands With Analysts
↗
April 29, 2024
Via
Benzinga
3 Small-Cap Stocks with Significant Growth Potential
↗
August 06, 2024
As sector rotation continues, it could be time for investors to consider these small-cap growth stocks that institutions love.
Via
InvestorPlace
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
June 03, 2024
Via
Benzinga
Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
May 24, 2024
Via
Benzinga
IMCR Stock Earnings: Immunocore Hldgs Misses EPS, Misses Revenue for Q1 2024
↗
May 08, 2024
IMCR stock results show that Immunocore Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Immunocore Hldgs Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
↗
April 11, 2024
Via
Benzinga
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
↗
March 13, 2024
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.
Via
InvestorPlace
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
